Oct 30, 2025 04:01PM
Nov 7, 2024 07:00AM
Aug 6, 2024 04:01PM
May 7, 2024 04:00PM
Feb 27, 2024 07:00AM
Nov 8, 2023 04:01PM
Sep 5, 2023 08:30AM Mirum Pharmaceuticals Completes Acquisition of Bile Acid Product Portfolio for Treatment of Rare Liver Diseases from Travere Therapeutics
Aug 8, 2023 04:01PM
Jul 17, 2023 08:00AM
Jul 17, 2023 08:00AM
Jul 17, 2023 08:00AM
Oct 27, 2022 04:01PM
Oct 27, 2022 04:01PM
Oct 13, 2022 05:24PM After-Hours Movers: Imara Gains on Merger, Travere Therapeutics Falls on PDUFA Delay
Aug 4, 2022 07:00AM
Aug 4, 2022 07:00AM
May 5, 2022 04:01PM
May 5, 2022 04:01PM
Feb 24, 2022 04:01PM
Feb 24, 2022 04:01PM
Oct 28, 2021 04:01PM Travere Therapeutics Reports Third Quarter 2021 Financial Results and Organizational Progress
Oct 28, 2021 04:01PM
Jul 29, 2021 04:01PM
Jul 29, 2021 04:01PM
May 6, 2021 04:01PM
May 6, 2021 04:01PM
Mar 1, 2021 04:01PM
Mar 1, 2021 04:01PM Travere Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results

1,156,800 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All